. "0"^^ . . . "0"^^ . . . . . "Neuvedeno."@en . . "The need for improved clinical protocols has prompted a search for new metal-based chemotherapeutic agents, such as those based on platinum and ruthenium compounds as well as a more complete understanding of the cellular mechanisms underlying both antitu"@en . . "Bun\u011B\u010Dn\u00E1 a molekul\u00E1rn\u00ED farmakologie protin\u00E1dorov\u011B \u00FA\u010Dinn\u00FDch slou\u010Denin platiny a rhutenia" . "St\u00E1le nar\u016Fstaj\u00EDc\u00ED pot\u0159eba zdokonalit chemoterapeutick\u00E9 postupy p\u0159i l\u00E9\u010Den\u00ED rakoviny vede k vyhled\u00E1v\u00E1n\u00ED nov\u00FDch cytostatik odvozen\u00FDch od komplex\u016F kov\u016F, jako jsou komplexy platiny a ruthenia. Toto vyhled\u00E1v\u00E1ni nov\u00FDch l\u00E9\u010Div je zalo\u017Een\u00E9 na v\u00FDsledc\u00EDch studi\u00ED ved" . "http://www.isvav.cz/projectDetail.do?rowId=GA305/01/0418"^^ . . "GA305/01/0418" . . "2008-05-30+02:00"^^ . . "Cellular and molecular pharmakology of platinum and ruthenium anticancer drugs"@en . . "11"^^ . . . "1"^^ . . "11"^^ . . "\u0158e\u0161itel\u00E9 v\u00FDznamn\u011B p\u0159isp\u011Bli k hlub\u0161\u00EDmu pochopen\u00ED mechanismu \u00FA\u010Dinku cis-platiny. Spr\u00E1vn\u011B v\u010Das roz\u0161\u00ED\u0159ili a zm\u011Bnili spektrum zkouman\u00FDch platinov\u00FDch analog\u016F a soust\u0159edili se na skupinu obsahuj\u00EDc\u00ED v molekule admanta.n. Na modelov\u00FDch bun\u011B\u010Dn\u00FDch n\u00E1dorov\u00FDch lini\u00EDc"@cs .